Prostate cancer decisions — 2026

The Board has remanded the case due to a failure to adequately discuss and discount any ameliorative or beneficial effects of the medications the Veteran used to treat his prostate cancer residuals.

The Board has granted service connection for obstructive sleep apnea, prostate cancer with benign prostatic hypertrophy, and diabetes mellitus type II from the date of the decision. These conditions are found to be directly related to the Veteran's military service.

The Veteran's spinal stenosis is due to his service-connected bladder cancer, and the Board has granted service connection for this condition.

The Veteran's initial rating for residuals of prostate cancer is denied as the evidence does not show recurrent urinary tract infections, urine leakage requiring absorbent materials, or obstructed voiding with intermittent or continuous catheterization.,The Veteran's initial rating for headaches is denied as there are no characteristic prostrating attacks averaging once a month over several months.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence to support a link between his in-service exposures and his current condition.

The Veteran's prostate cancer, status post radical prostatectomy, is rated at 60 percent from September 1, 2007. The effective date for service connection of depressive disorder is set to July 31, 2007.

The Board denied service connection for left knee condition, right knee condition, and prostate cancer.,There is no current diagnosis of a left knee disability or a right knee disability during the appeal period.

The Veteran's service-connected residuals of prostate cancer alone, combined with other disabilities rated at least 60 percent, meet the criteria for special monthly compensation (SMC) at the housebound rate. The decision grants SMC based on TDIU being warranted due to his service-connected disabilities.

The Board has determined that the Veteran's metastatic prostate cancer, which contributed to his death, was related to his in-service toxic exposures at Camp Lejeune.

The Veteran's appeal for service connection of prostate cancer was dismissed. His bilateral hearing loss disability and IVDS to include degenerative arthritis and spinal stenosis of the lumbar spine were granted with a rating of 40 percent prior to February 11, 2019.

The Veteran's prostate cancer and erectile dysfunction are granted service connection, but hypertension is remanded for further development.

Your appeals for increased compensation for hearing loss, service connection for prostate cancer, and service connection for pancreatic cancer have been dismissed due to the Veteran's death. The appeal will be closed.

The Veteran's prostate cancer is in remission, and he currently has urinary leakage requiring absorbent materials changed more than four times per day. The Board denied a higher rating for his prostate cancer prior to May 26, 2023, and from May 26, 2023 onwards.

The Veteran's prostate cancer is granted service connection due to presumed exposure to contaminated water at Camp Lejeune. The psychiatric disability, erectile dysfunction, and rectal disabilities are also remanded for further review.

The Veteran's adult disabled child, T.B., was added as a dependent effective January 25, 2021. The Board found the claim for service connection was pending since January 25, 2021 and granted the earlier effective date.

The Board denied service connection for prostate cancer, finding that the evidence does not support a link between the Veteran's current condition and his military service or toxic exposure risk activities.

The Veteran's initial evaluations for generalized anxiety disorder with major depressive disorder, prostate cancer, and erectile dysfunction were denied. The Board has remanded the issues of service connection for cervical spine disorder, right lower extremity radiculopathy, left lower extremity radiculopathy, and intention tremors.

The Board has granted a 60% disability rating for prostate cancer residuals, effective the date of reduction from May 12, 2025. The Veteran's previous 100% rating was reduced due to improvement in his condition.

The Veteran's claim for an increased rating for his service-connected right median nerve and carpal tunnel syndrome was granted with a 30 percent rating effective August 8, 2023. The Board also remanded the Veteran's claims for service connection for sleep apnea as secondary to PTSD.

The Board has granted service connection for the Veteran's back condition, but remanded the issues of service connection for bilateral eye condition, hypertension, DVT, and prostate cancer.